世界の急性骨髄性白血病市場は、予測期間の2023年から2030年には健全な成長率で成長すると予測されています。急性骨髄性白血病（AML）は、血液がんの一種で、骨髄に未熟な白血球が過剰に存在するものです。感染症との戦いを担う白血球の一種である未熟な骨髄系細胞が急速に増殖することが特徴です。AMLでは、これらの未熟な細胞が骨髄に集まり、健康な血液細胞の形成を阻害するため、症状や問題が発生します。急性骨髄性白血病の有病率の増加、新規治療法の導入の増加、精密医療の重視の高まり、免疫療法の採用の急増、医療費の増加が、全世界の市場需要に寄与する主要因です。
また、高齢者人口の増加は、世界的な市場成長の触媒として作用しています。米国がん協会によると、AMLは通常、高齢者の間で発生し、45歳以前はまれです。また、AMLの平均年齢は約68歳です。世界保健機関（WHO）の報告によると、高齢者の数は2020年の10億人から2030年には15億人に増加すると予想されており、世界では60歳以上の6人に1人が高齢者であるとされています。したがって、急速に増加する老年人口は、急性骨髄性白血病に罹患しやすく、市場成長のための有利な機会を生み出しています。さらに、薬学や分子生物学の進歩による医薬品開発の促進や、研究開発への投資の増加は、予測期間中にさまざまな有利な機会をもたらしています。例えば、2022年5月、FDAは、新たに診断された急性骨髄性白血病（AML）に対して、アザシチジン（azacitidine）と混合したイボシデニブ（ivosidenib）である、Servier Pharmaceuticals LLC社のチブソボ（Tibsovo）（注射用アザシチジン）を承認したと発表した。さらに、これには、75歳以上の成人、または集中的な導入化学療法を妨げる併存疾患を有する成人を対象としたFDA承認の検査によって特定された、感受性の高いIDH1変異が含まれています。ただし、薬物および化学療法に関連する合併症に対する厳しい規制により、2023年から2030年の予測期間を通じて市場の成長が制限されています。
急性骨髄性白血病の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカです。北アメリカは、急性骨髄性白血病患者の増加、技術的進歩の高まり、患者中心のアプローチへの注目の高まりにより、2022年の市場を支配しています。米国がん協会は、2023年に白血病の新規症例が約59,610件、白血病による死亡が23,710件であると述べています。一方、アジア太平洋地域は、政府の積極的な取り組み、臨床試験の実施数の増加、医療費の増加、分子診断の進歩の増加などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Acute Myeloid Leukemia Market, by Region, 2020-2030 (USD Billion)
1.2.2. Acute Myeloid Leukemia Market, by Chemotherapy, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Acute Myeloid Leukemia Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Acute Myeloid Leukemia Market Dynamics
3.1. Acute Myeloid Leukemia Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of acute myeloid leukemia
3.1.1.2. Rising geriatric population
3.1.2. Market Challenges
3.1.2.1. Stringent regulations on drugs
3.1.2.2. Complications related to chemotherapy
3.1.3. Market Opportunities
3.1.3.1. Rising advancements in pharmacology and molecular biology to promote drug development
3.1.3.2. Increasing investments in research and development
Chapter 4. Global Acute Myeloid Leukemia Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Acute Myeloid Leukemia Market, by Chemotherapy
5.1. Market Snapshot
5.2. Global Acute Myeloid Leukemia Market by Chemotherapy, Performance - Potential Analysis
5.3. Global Acute Myeloid Leukemia Market Estimates & Forecasts by Chemotherapy 2020-2030 (USD Billion)
5.4. Acute Myeloid Leukemia Market, Sub Segment Analysis
5.4.1. Cytarabine
5.4.2. Anthracycline Drugs
5.4.3. Alkylating Agents
5.4.4. Anti-metabolites
5.4.5. Tyrosine Kinase Inhibitors
5.4.6. Hormonal Therapy
5.4.7. Other Chemotherapies
Chapter 6. Global Acute Myeloid Leukemia Market, Regional Analysis
6.1. Top Leading Countries
6.2. Top Emerging Countries
6.3. Acute Myeloid Leukemia Market, Regional Market Snapshot
6.4. North America Acute Myeloid Leukemia Market
6.4.1. U.S. Acute Myeloid Leukemia Market
6.4.1.1. Chemotherapy breakdown estimates & forecasts, 2020-2030
6.4.2. Canada Acute Myeloid Leukemia Market
6.5. Europe Acute Myeloid Leukemia Market Snapshot
6.5.1. U.K. Acute Myeloid Leukemia Market
6.5.2. Germany Acute Myeloid Leukemia Market
6.5.3. France Acute Myeloid Leukemia Market
6.5.4. Spain Acute Myeloid Leukemia Market
6.5.5. Italy Acute Myeloid Leukemia Market
6.5.6. Rest of Europe Acute Myeloid Leukemia Market
6.6. Asia-Pacific Acute Myeloid Leukemia Market Snapshot
6.6.1. China Acute Myeloid Leukemia Market
6.6.2. India Acute Myeloid Leukemia Market
6.6.3. Japan Acute Myeloid Leukemia Market
6.6.4. Australia Acute Myeloid Leukemia Market
6.6.5. South Korea Acute Myeloid Leukemia Market
6.6.6. Rest of Asia Pacific Acute Myeloid Leukemia Market
6.7. Latin America Acute Myeloid Leukemia Market Snapshot
6.7.1. Brazil Acute Myeloid Leukemia Market
6.7.2. Mexico Acute Myeloid Leukemia Market
6.8. Middle East & Africa Acute Myeloid Leukemia Market
6.8.1. Saudi Arabia Acute Myeloid Leukemia Market
6.8.2. South Africa Acute Myeloid Leukemia Market
6.8.3. Rest of Middle East & Africa Acute Myeloid Leukemia Market
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Novartis AG
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Recent Developments
7.3.2. Genmab AS
7.3.3. Otsuka Holdings Co. Ltd
7.3.4. Sanofi-Aventis (Genzyme Corporation)
7.3.5. Teva Pharmaceutical Industries Ltd. (Cephalon Inc.)
7.3.6. Pfizer Inc.
7.3.7. F. Hoffmann-La Roche Ltd
7.3.8. Sunesis Pharmaceuticals Inc.
7.3.9. Astellas Pharma Inc.
7.3.10. Oncolyze Inc.
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption
List of Tables
TABLE 1. Global Acute Myeloid Leukemia Market, report scope
TABLE 2. Global Acute Myeloid Leukemia Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Acute Myeloid Leukemia Market estimates & forecasts by Chemotherapy 2020-2030 (USD Billion)
TABLE 4. Global Acute Myeloid Leukemia Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 5. Global Acute Myeloid Leukemia Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Acute Myeloid Leukemia Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Acute Myeloid Leukemia Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Acute Myeloid Leukemia Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Acute Myeloid Leukemia Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Acute Myeloid Leukemia Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Acute Myeloid Leukemia Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Acute Myeloid Leukemia Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Acute Myeloid Leukemia Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. U.S. Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 16. U.S. Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. Canada Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. Canada Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. UK Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. UK Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Germany Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. Germany Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. France Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. France Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Italy Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. Italy Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Spain Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Spain Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. RoE Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. RoE Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. China Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. China Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. India Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. India Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. Japan Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. Japan Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. South Korea Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. South Korea Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Australia Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. Australia Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. RoAPAC Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. RoAPAC Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Brazil Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. Brazil Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Mexico Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Mexico Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. RoLA Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. RoLA Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Saudi Arabia Acute Myeloid Leukemia Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. South Africa Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoMEA Acute Myeloid Leukemia Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Acute Myeloid Leukemia Market
TABLE 69. List of primary sources, used in the study of global Acute Myeloid Leukemia Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Acute Myeloid Leukemia Market, research methodology
FIG 2. Global Acute Myeloid Leukemia Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Acute Myeloid Leukemia Market, key trends 2022
FIG 5. Global Acute Myeloid Leukemia Market, growth prospects 2023-2030
FIG 6. Global Acute Myeloid Leukemia Market, porters 5 force model
FIG 7. Global Acute Myeloid Leukemia Market, pest analysis
FIG 8. Global Acute Myeloid Leukemia Market, value chain analysis
FIG 9. Global Acute Myeloid Leukemia Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Acute Myeloid Leukemia Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Acute Myeloid Leukemia Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Acute Myeloid Leukemia Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Acute Myeloid Leukemia Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Acute Myeloid Leukemia Market, regional snapshot 2020 & 2030
FIG 15. North America Acute Myeloid Leukemia Market 2020 & 2030 (USD Billion)
FIG 16. Europe Acute Myeloid Leukemia Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Acute Myeloid Leukemia Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Acute Myeloid Leukemia Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Acute Myeloid Leukemia Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
